Osaka, Japan

Naohisa Shobako

This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Nissin Foods Holdings Co., Ltd., Sunstar Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naohisa Shobako. Retrieved from https://idiyas.com/inventor/naohisa-shobako

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Naohisa Shobako: Innovator in Peptide Research

Introduction

Naohisa Shobako is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of peptide research, particularly in the development of compounds with therapeutic potential. His work focuses on innovations that can impact health and medicine.

Latest Patents

Naohisa Shobako holds a patent for "Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof." This patent describes a novel peptide with ACE inhibitory activity, specifically a tripeptide consisting of Leu-Arg-Ala. This innovation has potential applications in managing conditions related to hypertension.

Career Highlights

Shobako is associated with Sunstar Inc., a company known for its commitment to health and wellness products. His role at the company allows him to explore and develop innovative solutions in the field of biochemistry and pharmacology.

Collaborations

He collaborates with talented coworkers, including Yuutarou Ogawa and Atsushi Ishikado. Their combined expertise enhances the research and development efforts at Sunstar Inc.

Conclusion

Naohisa Shobako's work exemplifies the importance of innovation in the field of peptide research. His contributions have the potential to lead to significant advancements in health-related applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…